A new study claims that nearly 11 million more people could become infected with HIV, and 3 million could die by the end of the decade, due to foreign aid cuts impacting funding for HIV prevention and treatment.
Published in The Lancet HIV, the study estimates the potential public health impact of proposed foreign aid cuts by the five donor countries that account for 90% of all international HIV funding.
Those countries are the United States, the United Kingdom, France, Germany, and the Netherlands.
The greatest impact of the cuts would be felt in sub-Saharan Africa and among vulnerable or marginalized populations at higher risk of HIV, including children, injection-drug users, sex workers, and men who have sex with men, reports Politico.
The United States has slashed funding for the U.S. Agency for International Development, including funding for HIV treatment and prevention programs.
The President’s Emergency Plan for AIDS Relief, or PEPFAR, a program focusing on reducing HIV incidence globally funded through multiple government agencies — which has been credited with saving 26 million lives since its implementation in 2003 — is also at risk.
In February, the United Kingdom announced a planned cut to international spending, while the Netherlands is cutting foreign aid by 2.4 billion euros, or approximately $2.6 billion in U.S. dollars.
Germany and France cut their foreign aid budgets last year, representing a loss of about 3 billion euros.
Using mathematical modeling, researchers found that the planned reductions in international aid, plus discontinued PEPFAR support, could result in between 4.43 to 10.75 million new HIV infections by 2030. That could likely result in as many as 3 million HIV-related deaths, compared to the status quo.
The study found that if PEPFAR support were reinstated, the number of new infections would be reduced to 1.73 million with 61,000 HIV-related deaths. The impact of loss of funding was felt more acutely in countries that are heavily reliant upon international funding and in countries whee HIV rates among key populations.
The study coincides with warnings from HIV prevention advocates that the abrupt cancellation of USAID money would likely only accelerate the spread of HIV.
According to the Infectious Diseases Society of America and the HIV Medicine Association, dozens of USAID programs that implement PEPFAR have been shut down in countries with a high incidence of HIV.
Halting HIV treatment for those who have begun it can also lead to the development of drug-resistant HIV that would be much harder to control.
“The current cuts to PEPFAR and USAID-supported programs have already disrupted access to essential HIV services including for antiretroviral therapy and HIV prevention and testing,” Debra ten Brink, of the Burnet Institute, and the co-lead author of the study, told Politico in a statement. She warned that, if other donor countries also reduce their funding, “decades of progress to treat and prevent HIV could be unravelled.”
Whitman-Walker will host its 39th annual Walk & 5K to End HIV at Anacostia Park on Saturday, Sept. 20.
The event, which has served as the health organization's chief fundraiser for nearly four decades, brings together thousands of residents and local businesses -- some as corporate sponsors or fund-matching partners -- to raise money for Whitman-Walker's patient services.
This year marks the fourth time the event has been held east of the Anacostia River, in Southeast D.C., where many of Whitman-Walker's patients live and where HIV rates remain among the highest in the city.
On September 5, the World Health Organization declared that Africa's mpox outbreak is no longer considered an international health emergency.
The announcement was a relief for many in the LGBTQ community, as one variant, Clade II, spread rapidly among men who have sex with men (MSM). At the virus's peak, the United States reported nearly 500 cases per day.
The virus causes flu-like symptoms and, most notably, painful rashes, lesions, and scabbing. With an incubation period of 3 to 17 days, many people don't realize they are infected until visible symptoms appear.
Metro Weekly magazine was barely a year and a half old when, in 1995, we were offered the chance to interview — and photograph — Broadway legend Carol Channing, then appearing at the Kennedy Center in Hello, Dolly! that fall. Two moments from that experience stand out, the first at the photo shoot with Annie Adjchavanich.
We'd set up a black velvet backdrop in the Hall of States and were waiting for Miss Channing to arrive. When she finally swept in, she looked radiant. Except… she refused to remove her enormous sunglasses. Indoors.
I begged her to take them off, but she firmly declined. "I don't have my eyelashes on," she said. "You are not seeing me without my eyelashes!" And that was that — sunglasses it would be. The result was a cover that was both thrilling (Carol Channing!) and oddly surreal (Carol Channing in giant sunglasses!).
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.